rac-6-Chloro-3-nitro-2-(trifluoromethyl)-2H-chromene

ID: ALA5279730

Chembl Id: CHEMBL5279730

Max Phase: Preclinical

Molecular Formula: C10H5ClF3NO3

Molecular Weight: 279.60

Associated Items:

Names and Identifiers

Canonical SMILES:  O=[N+]([O-])C1=Cc2cc(Cl)ccc2OC1C(F)(F)F

Standard InChI:  InChI=1S/C10H5ClF3NO3/c11-6-1-2-8-5(3-6)4-7(15(16)17)9(18-8)10(12,13)14/h1-4,9H

Standard InChI Key:  MZKIMVRXOFRAQO-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA5279730

    ---

Associated Targets(Human)

P2RY6 Tchem Pyrimidinergic receptor P2Y6 (717 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DRD3 Tclin Dopamine D3 receptor (14368 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DRD5 Tchem Dopamine D5 receptor (1597 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

P2ry6 P2Y purinoceptor 6 (14 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 279.60Molecular Weight (Monoisotopic): 278.9910AlogP: 3.28#Rotatable Bonds: 1
Polar Surface Area: 52.37Molecular Species: NEUTRALHBA: 3HBD:
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: 3.14CX LogD: 3.14
Aromatic Rings: 1Heavy Atoms: 18QED Weighted: 0.59Np Likeness Score: -0.63

References

1. Jung YH, Shah Q, Lewicki SA, Pramanik A, Gopinatth V, Pelletier J, Sévigny J, Iqbal J, Jacobson KA..  (2022)  Synthesis and pharmacological characterization of multiply substituted 2H-chromene derivatives as P2Y6 receptor antagonists.,  75  [PMID:36089113] [10.1016/j.bmcl.2022.128981]

Source